News

MINIject STAR-II 12-month trial results at AGS

The 12-month results from the European STAR-II trial of iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM will be presented at the American Glaucoma Society (AGS) meeting.

MINIject in Ophthalmology Times Europe

An article in Ophthalmology Times Europe outlines how the suprachoroidal space promises to become a feasible route to effectively reduce intraocular pressure (IOP) in patients with glaucoma, thanks to iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM.

MINIject in Glaucoma Physician journal

In the latest issue of Glaucoma Physician, iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM features as a prominent solution to unlock the potential of the suprachoroidal space in glaucoma treatment.

MINIject’s 2020 results at EGS

The 2020 results from trials of minimally invasive glaucoma surgery (MIGS) device MINIjectTM will be presented at the upcoming European Glaucoma Society (EGS) annual meeting on 12-13 December. The consistently positive data showed outstanding results of intraocular pressure (IOP) and medication reduction in patients with open angle glaucoma, and a positive safety profile across trials. […]

iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial

Growing body of evidence confirms MINIject is safe and effective with results sustained over time